Hepatocellular cancer, transplantation, and sirolimus

Liver Transplantation

Volumn 10, Issue 10, 2004, Pages 1312-1314

  Wall, William J ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; DACLIZUMAB; GRANULOCYTE COLONY STIMULATING FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ANEMIA; ANTINEOPLASTIC ACTIVITY; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL PROTOCOL; CLINICAL TRIAL; DIABETES MELLITUS; DOSE CALCULATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG WITHDRAWAL; EDITORIAL; FOLLOW UP; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; MOUTH ULCER; NEPHROTOXICITY; NEUROTOXICITY; PATIENT SELECTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; SIROLIMUS;

EID: 6444223561     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20283     Document Type: Editorial

References (16)

1. Sehgal S, Molnar-Kimber K, Ocain T, Weichman B. Rapamycin: A novel macrolide. Med Res Rev 1994;14:1-17.
2. Price DJ, Grove JR, Calvo V, Avrich J, Bierer BE. Rapamycininduced inhibition of the 70-kilodalton S6 protein kinase. Science 1992;257:973-977.
3. Guba M, vonBreitenbach P, Steinbauer M, Koehl G, Flegel S, Hornug M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: Involvement of vascular endothelial growth factor. Nat Med 2002;8:128-135.
4. Watson CJE, Friend PJ, Jamieson NV, Frick TW, Alexander G, Gimson AE, Calne R. Sirolimus: A potent new immunosuppressant for liver transplantation. Transplantation 1999;67:505-509.
5. Kneteman NM, Oberholzer J, Al Saghier M, Meeberg GA, Blitz M, Bigam DL, et al. Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Liver Transpl 2004;10:1301-1311.
6. Trotter JF, Wachs M, Bak T, Trouillot T, Stolpman N, Ewerson GT, Kam I. Liver transplantation using sirolimus and minimal corticosteroids (3-day taper). Liver Transpl 2001;7:343-351.
7. McAlister VC, Peltekian KM, Malatjalian DA, Colohan S, Macdonald S, Bitter-Suermann H, MacDonald AS. Orthotopic liver transplant using low-dose tacrolimus and sirolimus. Liver Transpl 2001;7:701-708.
8. Fisher A, Sequel JM, dela Torre AN, Wilson D, Merchant A, Arora RK, Koneru B. Effect of Sirolimus on infection incidence in liver transplant recipients. Liver Transpl 2004; 10:193-198.
9. Mazzaferro V, Regalila E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 1996;334:693-699.
10. Figuera SJ, Jaurrieta E, Valls C, Benasco C, Rafecas A, Xiol X, et al. Survival after liver transplantation in cirrhotic patients with an without hepatocellular carcinoma: A comparative study. Hepatology 1997;25:1485-1489.
11. Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 1998;27:1572-1583.
12. Khakhar A, Solano E, Stell D, Bloch M, Dale C, Burns P, et al. Survival after liver transplantation for hepatocellular cancer. Transpl Proc 2003;35:2438-2441.
13. DeCarlis L, Giacomoni A, Pirotta V, Lauterio A, Slim AO, Sammartino C, et al. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. J Am Coll Surg 2003; 196: 887-889.
14. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403.
15. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TMN criteria. Liver Transpl 2002;8:765-773.
16. Herrero JI, Sangro B, Quiroga J, Pardo F, Herraiz M, Cienfuegos JA, Prieto J. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl 2001;7:631-636.